Continued from page 1

In order to ensure the safety and efficacy of medicines and confidence in commerce, governments and individuals must make combating the counterfeiting of drugs a high priority. As economist Roger Bate has written, “Until international bodies clean up their act and stop blurring the boundaries between safe medicines and substandard copies and until there are harsh local and international penalties for manufacturing and carrying counterfeits, the pirates will continue to get away with murder.”

Dr. Henry I. Miller, a physician and fellow at Stanford University’s Hoover Institution, was an official at the FDA from 1979 to 1994. His most recent book is “The Frankenfood Myth” (Praeger, 2004).